Work

Phase I/II study of the safety, pharmacokinetics, and efficacy of pomalidomide in the treatment of Kaposi sarcoma in individuals with or without HIV.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.tps10595

Authors: Mark Niccolo Polizzotto, Thomas S. Uldrick, Kathleen Wyvill, Karen Aleman, Irini Sereti, Giovanna Tosato, Denise Whitby, Margaret Bevans, Frank Maldarelli, William Douglas Figg, Seth M. Steinberg, Robert Yarchoan

Institutions: National Cancer Institute, Center for Cancer Research, National Institute of Allergy and Infectious Diseases, Frederick National Laboratory for Cancer Research, National Institutes of Health, National Institutes of Health Clinical Center

Language: English

Topic: Viral-associated cancers and disorders

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603594152

Cites:

Cited by:

Related to: 10